NVSEF - Olema posts Phase 1/2 data for lead asset in breast cancer
2023-12-05 13:28:55 ET
More on Olema Pharmaceuticals
- Olema Pharmaceuticals: Advancing On Multiple Fronts
- Olema: Two-Pronged Approach To Treat Breast Cancer Patients
- Olema Pharmaceuticals officer discloses sale of about 10K shares
- Seeking Alpha’s Quant Rating on Olema Pharmaceuticals
- Historical earnings data for Olema Pharmaceuticals
For further details see:
Olema posts Phase 1/2 data for lead asset in breast cancer